Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy (1807)    NLM VALUE SETS (802.2)

Name Value
NAME Use of Systemic Sympathetic alpha-1a Antagonist Medication for Treatment of Prostatic Hypertrophy
OID 2.16.840.1.113883.3.526.3.1442
SHORT ID UOSSA1AMFTOPH42
VERSION DATE 2017-01-06 00:00:00
CODE LIST
  • CODES:
    • CODE DESCRIPTION:   
      Doxazosin 1 MG Oral Tablet
    • CODE DESCRIPTION:   
      Polythiazide 0.5 MG / Prazosin 5 MG Oral Capsule
    • CODE DESCRIPTION:   
      Prazosin 1 MG Oral Capsule
    • CODE DESCRIPTION:   
      Prazosin 2 MG Oral Capsule
    • CODE DESCRIPTION:   
      Terazosin 1 MG Oral Capsule
    • CODE DESCRIPTION:   
      Terazosin 2 MG Oral Capsule
    • CODE DESCRIPTION:   
      Terazosin 5 MG Oral Capsule
    • CODE DESCRIPTION:   
      24 HR Doxazosin 4 MG Extended Release Oral Tablet
    • CODE DESCRIPTION:   
      24 HR Doxazosin 8 MG Extended Release Oral Tablet
    • CODE DESCRIPTION:   
      24 HR Alfuzosin hydrochloride 10 MG Extended Release Oral Tablet
    • CODE DESCRIPTION:   
      Phenoxybenzamine Hydrochloride 10 MG Oral Capsule
    • CODE DESCRIPTION:   
      Doxazosin 2 MG Oral Tablet
    • CODE DESCRIPTION:   
      Tamsulosin hydrochloride 0.4 MG Oral Capsule
    • CODE DESCRIPTION:   
      Dutasteride 0.5 MG / Tamsulosin hydrochloride 0.4 MG Oral Capsule
    • CODE DESCRIPTION:   
      {30 (Prazosin 5 MG Oral Capsule) } Pack
    • CODE DESCRIPTION:   
      Doxazosin 4 MG Oral Tablet
    • CODE DESCRIPTION:   
      Doxazosin 8 MG Oral Tablet
    • CODE DESCRIPTION:   
      Prazosin 5 MG Oral Capsule
    • CODE DESCRIPTION:   
      Prazosin 5 MG Oral Tablet
    • CODE DESCRIPTION:   
      Terazosin 10 MG Oral Capsule
    • CODE DESCRIPTION:   
      Polythiazide 0.5 MG / Prazosin 1 MG Oral Capsule
    • CODE DESCRIPTION:   
      Polythiazide 0.5 MG / Prazosin 2 MG Oral Capsule
MEASURE LIST